| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
National Research Laboratory for Glycobiology, MOST, Korean Government, Kyungju 780-714, South Korea [T-W. C., C-H. K.]; Department of Biochemistry and Molecular Biology, Dongguk University COM, Kyungju 780-714, South Korea [T-W. C., C-H. K.]; Faculty of Natural Resources and Life Science, Dong-A University, Pusan 604-714, South Korea [Y-C. L.]; and Proteome Research Laboratory, Korea Research Institute of Bioscience and Biotechnology, Yusong, Daejon 305-333, South Korea [J-H. K.]
The Hepatitis B Virus X (HBx) protein of hepatitis B virus plays a major role in hepatocellular carcinoma. It has been reported that the mutation and disruption of PTEN, a known tumor suppressor and a negative regulator of phosphatidylinositol 3'-kinase/AKT might be involved in tumor progression. However, the relationship between HBx and PTEN expression in hepatocellular carcinoma (HCC) development is not fully understood. This study reports on an investigation of whether PTEN expression in HBx-transfected cells is modulated by HBx or not. HBx decreased the expression of PTEN in HBx-transfected cells, as evidenced by Western as well as Northern blot analysis. In addition, AKT was found to be activated by HBx, as evidenced by not only the phosphorylation of AKT at serine 473 but by the phosphorylation of the exogenous substrate histone H2B as well, and these were specifically blocked by the presence of wortmannin. Moreover, The growth rate of HBx-transfected liver cells was higher than that of Chang and Chang-pEGFP cells. HBx had no effect on the expression of p53, a known transcriptional activator of PTEN. However, we confirmed that the binding of the p53 protein to p53 binding site-oligo of PTEN promoter is decreased in HBx-transfected liver cells by electrophoretic mobility shift analysis and, in addition, that HBx disrupts p53-mediated PTEN transcription, as evidenced by a PTEN promoter assay. Therefore, we conclude that HBx in liver cells down-regulates the expression of PTEN and activates AKT. This constitutes the first report to demonstrate that HBx has an effect on the p53-mediated transcription of PTEN, which, in turn, is associated with tumor suppression.
This article has been cited by other articles:
![]() |
M. Han, W. Yan, W. Guo, D. Xi, Y. Zhou, W. Li, S. Gao, M. Liu, G. Levy, X. Luo, et al. Hepatitis B Virus-induced hFGL2 Transcription Is Dependent on c-Ets-2 and MAPK Signal Pathway J. Biol. Chem., November 21, 2008; 283(47): 32715 - 32729. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Choi, T.-W. Chung, S.-J. Kim, S.-Y. Cho, Y.-S. Lee, Y.-C. Lee, J.-H. Ko, and C.-H. Kim The AP-2{alpha} transcription factor is required for the ganglioside GM3-stimulated transcriptional regulation of a PTEN gene Glycobiology, May 1, 2008; 18(5): 395 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Meng, R. Henson, and T. Patel Chemotherapeutic stress selectively activates NF-{kappa}B-dependent AKT and VEGF expression in liver cancer-derived endothelial cells Am J Physiol Cell Physiol, August 1, 2007; 293(2): C749 - C760. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Casavant, M. H. Luo, K. Rosenke, T. Winegardner, A. Zurawska, and E. A. Fortunato Potential Role for p53 in the Permissive Life Cycle of Human Cytomegalovirus. J. Virol., September 1, 2006; 80(17): 8390 - 8401. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Choi, T.-W. Chung, S.-K. Kang, Y.-C. Lee, J.-H. Ko, J.-G. Kim, and C.-H. Kim Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21WAF1 and p27kip1 by inhibition of PI-3K/AKT pathway Glycobiology, July 1, 2006; 16(7): 573 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Agrawal and C. Eng Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer Hum. Mol. Genet., March 1, 2006; 15(5): 777 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-W. Chung, H.-J. Choi, Y.-C. Lee, and C.-H. Kim Molecular mechanism for transcriptional activation of ganglioside GM3 synthase and its function in differentiation of HL-60 cells Glycobiology, March 1, 2005; 15(3): 233 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-W. CHUNG, S.-K. MOON, Y.-C. CHANG, J.-H. KO, Y.-C. LEE, G. CHO, S.-H. KIM, J.-G. KIM, and C.-H. KIM Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism FASEB J, November 1, 2004; 18(14): 1670 - 1681. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Kang, T.-W. Chung, J.-Y. Lee, Y.-C. Lee, R. E. Morton, and C.-H. Kim The Hepatitis B Virus X Protein Inhibits Secretion of Apolipoprotein B by Enhancing the Expression of N-Acetylglucosaminyltransferase III J. Biol. Chem., July 2, 2004; 279(27): 28106 - 28112. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yun, H. Cho, S.-J. Kim, J.-H. Lee, S. Y. Park, G. K. Chan, and H. Cho Mitotic Aberration Coupled With Centrosome Amplification Is Induced by Hepatitis B Virus X Oncoprotein via the Ras-Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase-Mitogen-Activated Protein Pathway Mol. Cancer Res., March 1, 2004; 2(3): 159 - 169. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |